Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Barry R Meisenberg"'
Autor:
Justin J Turcotte, Barry R Meisenberg, James H MacDonald, Nandakumar Menon, Marcia B Fowler, Michaline West, Jane Rhule, Sadaf S Qureshi, Eileen B MacDonald
Publikováno v:
PLoS ONE, Vol 15, Iss 8, p e0237558 (2020)
BackgroundThe Covid-19 pandemic threatens to overwhelm scarce clinical resources. Risk factors for severe illness must be identified to make efficient resource allocations.ObjectiveTo evaluate risk factors for severe illness.DesignRetrospective, obse
Externí odkaz:
https://doaj.org/article/3a01069f5e6246b7952de77fb0f6ef99
Autor:
Anusha Yarava, Christi Marshall, David E. Reichert, Aaron Ye, Preeti Khanal, Sanford H. Robbins, Bruce S. Sachais, David Oh, Ryan A. Metcalf, Kathleen Conry-Cantilena, Karen King, Meredith Reyes, Jill Adamski, Marisa B. Marques, Minh-Ha Tran, Elizabeth S. Allen, Daniel Pach, Neil Blumberg, Rhonda Hobbs, Tammon Nash, Aarthi G. Shenoy, Giselle S. Mosnaim, Yuriko Fukuta, Bela Patel, Sonya L. Heath, Adam C. Levine, Barry R. Meisenberg, Shweta Anjan, Moises A. Huaman, Janis E. Blair, Judith S. Currier, James H. Paxton, William Rausch, Kevin Oei, Matthew Abinante, Donald N. Forthal, Martin S. Zand, Seble G. Kassaye, Edward R. Cachay, Kelly A. Gebo, Shmuel Shoham, Arturo Casadevall, Nichol A. McBee, Daniel Amirault, Ying Wang, Erica Hopkins, David M. Shade, Oliver Layendecker, Sabra L. Klein, Han-Sol Park, John S. Lee, Patrizio Caturegli, Jay S. Raval, Daniel Cruser, Alyssa F. Ziman, Jonathan Gerber, Thomas J. Gniadek, Evan M. Bloch, Aaron A.R. Tobian, Daniel F. Hanley, David J. Sullivan, Karen Lane, the CSSC (COVID 19 Serologic Studies Consortium) group
Publikováno v:
Journal of Clinical and Translational Science, Vol 8 (2024)
Abstract Introduction: In response to the COVID-19 pandemic, we rapidly implemented a plasma coordination center, within two months, to support transfusion for two outpatient randomized controlled trials. The center design was based on an investigat
Externí odkaz:
https://doaj.org/article/01c44018ad0a40a9b7d918fb0c80348c
Autor:
Han-Sol Park, Caelan Barranta, Anna Yin, John S. Lee, Christopher A. Caputo, Maggie Li, Steve Yoon, Ioannis Sitaras, Anne Jedlicka, Yolanda Eby, Malathi Ram, Reinaldo E. Fernandez, Owen R. Baker, Aarthi G. Shenoy, Giselle S. Mosnaim, Yuriko Fukuta, Bela Patel, Sonya L. Heath, Adam C. Levine, Barry R. Meisenberg, Emily S. Spivak, Shweta Anjan, Moises A. Huaman, Janis E. Blair, Judith S. Currier, James H. Paxton, Jonathan M. Gerber, Joann R. Petrini, Patrick B. Broderick, William Rausch, Marie Elena Cordisco, Jean Hammel, Benjamin Greenblatt, Valerie C. Cluzet, Daniel Cruser, Kevin Oei, Matthew Abinante, Laura L. Hammitt, Catherine G. Sutcliffe, Donald N. Forthal, Martin S. Zand, Edward R. Cachay, Jay S. Raval, Seble G. Kassaye, Christi E. Marshall, Anusha Yarava, Karen Lane, Nichol A. McBee, Amy L. Gawad, Nicky Karlen, Atika Singh, Daniel E. Ford, Douglas A. Jabs, Lawrence J. Appel, David M. Shade, Bryan Lau, Stephan Ehrhardt, Sheriza N. Baksh, Janna R. Shapiro, Jiangda Ou, Thomas J. Gniadek, Patrizio Caturegli, Jinke Wu, Nelson Ndahiro, Michael J. Betenbaugh, Alyssa Ziman, Daniel F. Hanley, Arturo Casadevall, Shmuel Shoham, Evan M. Bloch, Kelly A. Gebo, Aaron A.R. Tobian, Oliver Laeyendecker, Andrew Pekosz, Sabra L. Klein, David J. Sullivan
Publikováno v:
medRxiv
SARS-CoV-2 antibody levels associated with reduced hospitalization risk remain undefined. Our outpatient COVID-19 convalescent plasma (CCP), placebo-controlled trial observed SARS-CoV-2 antibody levels decreasing 22-fold from matched donor units into
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::124d32fa90320c1ef7c7c5ee968c932a
https://europepmc.org/articles/PMC10153328/
https://europepmc.org/articles/PMC10153328/
Autor:
David J. Sullivan, Kelly A. Gebo, Shmuel Shoham, Evan M. Bloch, Bryan Lau, Aarthi G. Shenoy, Giselle S. Mosnaim, Thomas J. Gniadek, Yuriko Fukuta, Bela Patel, Sonya L. Heath, Adam C. Levine, Barry R. Meisenberg, Emily S. Spivak, Shweta Anjan, Moises A. Huaman, Janis E. Blair, Judith S. Currier, James H. Paxton, Jonathan M. Gerber, Joann R. Petrini, Patrick B. Broderick, William Rausch, Marie-Elena Cordisco, Jean Hammel, Benjamin Greenblatt, Valerie C. Cluzet, Daniel Cruser, Kevin Oei, Matthew Abinante, Laura L. Hammitt, Catherine G. Sutcliffe, Donald N. Forthal, Martin S. Zand, Edward R. Cachay, Jay S. Raval, Seble G. Kassaye, E. Colin Foster, Michael Roth, Christi E. Marshall, Anusha Yarava, Karen Lane, Nichol A. McBee, Amy L. Gawad, Nicky Karlen, Atika Singh, Daniel E. Ford, Douglas A. Jabs, Lawrence J. Appel, David M. Shade, Stephan Ehrhardt, Sheriza N. Baksh, Oliver Laeyendecker, Andrew Pekosz, Sabra L. Klein, Arturo Casadevall, Aaron A.R. Tobian, Daniel F. Hanley
Publikováno v:
New England Journal of Medicine. 386:1700-1711
Polyclonal convalescent plasma may be obtained from donors who have recovered from coronavirus disease 2019 (Covid-19). The efficacy of this plasma in preventing serious complications in outpatients with recent-onset Covid-19 is uncertain.In this mul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d805419a23313d393a2c761fef5c62c
https://doi.org/10.1056/nejmoa2119657
https://doi.org/10.1056/nejmoa2119657
Autor:
Cathaleen A Ley, Christian M Cintron, Karen L McCamant, Mitchell B Karpman, Barry R Meisenberg
Publikováno v:
Nursing Ethics. 29:787-801
Background Duty to care is integral to nursing practice. Personal obligations that normally conflict with professional obligations are likely amplified during a public health emergency such as COVID-19. Organizations can facilitate a nurse’s abilit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f51d7e56eb9b9c6f283c35c706c1e68e
https://doi.org/10.1177/09697330211057192
https://doi.org/10.1177/09697330211057192
Autor:
Adam C. Levine, Yuriko Fukuta, Moises A. Huaman, Jiangda Ou, Barry R. Meisenberg, Bela Patel, James H. Paxton, Daniel F. Hanley, Bart JA Rijnders, Arvind Gharbharan, Casper Rokx, Jaap Jan Zwaginga, Andrea Alemany, Oriol Mitjà, Dan Ouchi, Pere Millat-Martinez, Valerie Durkalski-Mauldin, Frederick K. Korley, Larry J. Dumont, Clifton W. Callaway, Romina Libster, Gonzalo Perez Marc, Diego Wappner, Ignacio Esteban, Fernando Polack, David J. Sullivan
Publikováno v:
medRxiv
BackgroundMonoclonal antibody and antiviral treatments for COVID-19 disease remain largely unavailable worldwide, and existing monoclonal antibodies may be less active against circulating omicron variants. Although treatment with COVID-19 convalescen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a1db9aac5bb191d8876a2591ee212f3
https://pubmed.ncbi.nlm.nih.gov/36561181
https://pubmed.ncbi.nlm.nih.gov/36561181
Autor:
Stephen Selinger, Colleen G. Koch, Maureen van Stone, Elizabeth Lee Daugherty Biddison, Jose I. Suarez, Yoram Unguru, Michael R. Ehmann, Sherita Hill Golden, Danielle J. Doberman, Eric A. Gehrie, Derek M. Fine, Karen D’Souza, Mark T. Hughes, Amanda B. Levin, Jeffrey P. Natterman, Jason J. Marx, Barry R. Meisenberg, Adam Sapirstein, Cynda Hylton Rushton, R. Scott Stephens, Jeffrey P. Kahn, Eric Toner, Elizabeth K. Zink, Peter M. Hill, Allen Kachalia, Brian T. Garibaldi, Ayse P. Gurses, Harolyn M. E. Belcher
Publikováno v:
Chest
The coronavirus disease 2019 pandemic may require rationing of various medical resources if demand exceeds supply. Theoretical frameworks for resource allocation have provided much needed ethical guidance, but hospitals still need to address objectiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac79420e6813f6a61e8ff74df211913f
https://doi.org/10.1016/j.chest.2020.09.246
https://doi.org/10.1016/j.chest.2020.09.246
How do I implement an outpatient program for the administration of convalescent plasma for COVID-19?
Autor:
Evan M. Bloch, Aaron A. R. Tobian, Shmuel Shoham, Daniel F. Hanley, Thomas J. Gniadek, Edward R. Cachay, Barry R. Meisenberg, Kimberly Kafka, Christi Marshall, Sonya L. Heath, Aarthi Shenoy, James H. Paxton, Adam Levine, Donald Forthal, Yuriko Fukuta, Moises A. Huaman, Alyssa Ziman, Jill Adamski, Jonathan Gerber, Daniel Cruser, Seble G. Kassaye, Giselle S. Mosnaim, Bela Patel, Ryan A. Metcalf, Shweta Anjan, Ronald B. Reisler, Anusha Yarava, Karen Lane, Nichol McBee, Amy Gawad, Jay S. Raval, Martin Zand, Matthew Abinante, Patrick B. Broderick, Arturo Casadevall, David Sullivan, Kelly A. Gebo
Publikováno v:
Transfusion. 62(5)
Convalescent plasma, collected from donors who have recovered from a pathogen of interest, has been used to treat infectious diseases, particularly in times of outbreak, when alternative therapies were unavailable. The COVID-19 pandemic revived inter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83ed9337e25b141702411e25f2796202
https://pubmed.ncbi.nlm.nih.gov/35352362
https://pubmed.ncbi.nlm.nih.gov/35352362
Autor:
Maggie, Li, Evan J, Beck, Oliver, Laeyendecker, Yolanda, Eby, Aaron Ar, Tobian, Patrizio, Caturegli, Camille, Wouters, Gregory R, Chiklis, William, Block, Robert, McKie, Michael, Joyner, Timothy D, Wiltshire, Allan B, Dietz, Thomas J, Gniadek, Arell, Shapiro, Anusha, Yarava, Karen, Lane, Daniel, Hanley, Evan M, Bloch, Shmuel, Shoham, Edward R, Cachay, Barry R, Meisenberg, Moises A, Huaman, Yuriko, Fukuta, Bela, Patel, Sonya L, Heath, Adam C, Levine, James H, Paxton, Shweta, Anjan, Jonathan M, Gerber, Kelly A, Gebo, Arturo, Casadevall, Andrew, Pekosz, David J, Sullivan
The ongoing evolution of SARS-Co-V2 variants to omicron severely limits available effective monoclonal antibody therapies. Effective drugs are also supply limited. Covid-19 convalescent plasma (CCP) qualified for high antibody levels effectively redu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6199d9acbccaa1d265935e09706859a2
https://doi.org/10.1101/2022.03.01.22271662
https://doi.org/10.1101/2022.03.01.22271662
Autor:
Maggie Li, Evan J. Beck, Oliver Laeyendecker, Yolanda Eby, Aaron A. R. Tobian, Patrizio Caturegli, Camille Wouters, Gregory R. Chiklis, William Block, Robert O. McKie, Michael J. Joyner, Timothy D. Wiltshire, Allan B. Dietz, Thomas J. Gniadek, Arell J. Shapiro, Anusha Yarava, Karen Lane, Daniel F. Hanley, Evan M. Bloch, Shmuel Shoham, Edward R. Cachay, Barry R. Meisenberg, Moises A. Huaman, Yuriko Fukuta, Bela Patel, Sonya L. Heath, Adam C. Levine, James H. Paxton, Shweta Anjan, Jonathan M. Gerber, Kelly A. Gebo, Arturo Casadevall, Andrew Pekosz, David J. Sullivan
Publikováno v:
Blood advances. 6(12)
The ongoing evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants severely limits available effective monoclonal antibody therapies. Effective drugs are also supply limited. COVID-19 convalescent plasma (CCP) qualified fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e26bdc54a4450c93012320f8738fbb00
https://pubmed.ncbi.nlm.nih.gov/35262085
https://pubmed.ncbi.nlm.nih.gov/35262085